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ABSTRACT: 
— Background: This study reviews recent trends of HIV inpatient admissions over 5 Infectious diseases Units
in Liguria, in 2012.
— Patients and Methods: Five infectious diseases Units in Liguria, Italy, collected data on inpatient HIV ad-
missions from January to December 2012, including patient demographic, discharge diagnosis, CD4 T-
cell count, viral load (VL) and combined anti-retroviral treatment (cART).
— Results: Rate of patient admissions per 100 years was 6.12 (number=257), in 62.6% (n=161) of admissions
a VL under 50 copies/ml was observed. Furthermore, 86.4% (n=222) of admissions were on active cART.
Median age was 49 years. Mortality rate was 10.2%. Hepatitis C coinfection occurred in 64.6% of patients
(n=166). The most common diagnosis was infectious diseases (29.1%), respiratory diseases (16.6%) and
neoplasms (15.%). Chronic HCV infection and its complications (cirrhosis and hepatocellular carcinoma) ac-
counted for 31% of all discharging diagnosis.
— Conclusions: The majority of inpatients admitted during 2012 in our Units were on cART and virologically
suppressed. The complications of hepatitis C coinfection have a major impact on mortality rates and hos-
pitalization rates in Italy. According to these observations, the availability of new drugs for chronic hepatitis
C imposes a further effort to improve the quality of life of our patients.
— Key words: Hospital admissions, Hepatitis C virus, HIV.
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INTRODUCTION
The introduction of combined antiretroviral treatment
(cART) has reduced HIV associated morbidity and mor-
tality1 as opportunistic infections rates have declined2.
Yet the mortality rates remain three to fifteen times
higher in patients living with HIV than those observed in
the general population3,4, since non infectious co-mor-
bidities (NICMs) are becoming more apparent as the pop-
ulation starts to age5-8. This has been demonstrated in
studies of premature age-related comorbidities9 and
higher hospitalisation rates amongst patients living with
HIV compared to the general population10. The future im-
pact of NICMs on patient care and service provision is
still unfolding and information on current trends may be
helpful in planning future services. The aim of this study
is to describe the clinical characteristics and demograph-
ics of inpatient admissions in a net of Italian hospitals
that provide dedicated HIV care. 
PATIENTS AND METHODS
Four infectious disease Units (Sanremo, Galliera, San
Martino, La Spezia) in Liguria, Italy, collectively known
as the Analisi-Costi-Terapia-Antivirale network
(ACTeA), were involved in the study. These centres were
chosen due to their mutual interest and national universal
health care systems.
Liguria accounts for about 700,000 inhabitants with
3,000 HIV patients attending one of the collective serv-
ices. All hospital medical admissions of patients living
with HIV from 1st January to 31st December 2012 were
reviewed in this study. Surgical, paediatrics, obstetrics
and gynaecological admissions were not included.
The ACTeA prospectively collected patient data via
“The Ligurian HIV Clinical Network”11, an online plat-
form for collaborative studies in the field of HIV in
Northwest Italy. 
All centres coded admissions according the Interna-
tional Statistical Classification of Diseases (ICD) 9, and
all Units have been standardised to allow comparison
with the Z score formula. Only the principal clinical con-
dition for hospitalisation was recorded by the lead clinical
physician in the ACTeA or from the information recorded
on discharge summaries. All data were anonymised and
stored securely. Data categories collected for each patient
are reported in Table 1. 
For standardisation, viral loads below 50 copies/ml
was included into the category of viral suppression ac-
cording to Italian guidelines12.
Data regarding cART were based on information from
the last patient contact before the admission or on admis-
sion and were classified as: newly started (<6 months),
stable (>6 months), poor adherence (if the adherence was
below 80%, or clinicians had noted in the medical
records or self-suspended), and failing regimen (if the pa-
tients required a switch of treatment). 
For the opportunistic infections definition the follow-
ing index diseases were used: Cytomegalovirus infection,
Toxoplasma gondii encephalitis, Pneumocystis jirovecii
pneumonia (PCP), pulmonary tuberculosis (TB), dissem-
inated TB and TB lymphadenopathy, Mycobacterium
avium complex (MAC) disease, Cryptococcus spp. infec-
tion, recurrent pneumonia (>2 episodes in one year)13.
ICD categories that reached a 3% threshold of total
admissions were reviewed. Within each category, condi-
tions that constituted 50% of the total ICD are discussed. 
Fisher’s exact or Pearson chi square test were used to
compare categorical variables, while Mann-Whitney U
test was used for continuous variables. Distribution of
admission rate by country was estimated by negative bi-
nomial regression and the likelihood ratio test.
All analyses were performed with SPSS software
(IBM Corp. Released 2011. IBM SPSS Statistics for
Windows, Version 20.0. Armonk, NY, USA: IBM Corp)
and STATA (StataCorp. 2009. Stata Statistical Software:
Release 11. College Station, TX, USA: StataCorp LP). 
RESULTS
A total of 257 admissions for 205 patients were identified
(Table 2). The rate of patient admissions per 100 years
was 6.12. The average number of admissions per patient
throughout the one year period was 1.3, with a range of
1-7 admissions; 61.5% (n=126/215) of patients were
coinfected with Hepatitis C. The percentage of admis-
sions with a CD4 count above 200 cells/µl was 68.1%
(n=175). In 86.4% (n=222) of all admissions, the patient
was on cART, in 62.6% (n=161) of admissions the most
recent viral load was under 50 copies/ml. Among the pa-
tients on active cART (n=222): 73% (n=162) were on
treatment for more than 6 months and 1.8% (n=4) had
started cART less than 6 months prior to admission. Poor
adherence was observed in 22% (n=49), a failing regimen
was reported in 1.8% (n=4); self-suspension before ad-
mission occurred in 1.4% (n=3). The median viral load
in non-suppressed patients (all patients on and off cART
with VL RNA >50 copies/ml) was 4.36 log copies/ml.
Mortality rate of patients admitted during the study
was 10.2% (n=21/205), a breakdown of discharge desti-
nations is reported in Table 3. 
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Table 1. ICD9 codes.
ICD 9           Title
001-139        Certain infectious and parasitic diseases
140-239        Neoplasms
280-289        Diseases of the blood and blood-forming 
                     organs and certain disorders involving 
                     the immune mechanism
240-279        Endocrine, nutritional and metabolic diseases
290-319        Mental and behavioural disorders
320-359        Diseases of the nervous system
360-389        Diseases of the eye and adnexa 
                     (diseases of the sense organs code related to eyes)
360-389        Diseases of the ear and mastoid process 
                     (diseases of the sense organs codes related to ear)
390-459        Diseases of the circulatory system
460-519        Diseases of the respiratory system
520-579        Diseases of the digestive system
680-709        Diseases of the skin and subcutaneous tissue
710-739        Diseases of the musculoskeletal system 
                     and connective tissue
580-629        Diseases of the genitourinary system
630-679        Pregnancy, childbirth and the puerperium
760-779        Certain conditions originating 
                     in the perinatal period
740-759        Congenital malformations, deformations 
                     and chromosomal abnormalities
780-799        Symptoms, signs and abnormal clinical and 
                     laboratory findings, not elsewhere classified
800-999        Injury, poisoning and certain other consequences 
                     of external causes
Amongst the infectious and parasitic diseases admis-
sions, the most commonly observed discharge diagnosis
was chronic hepatitis C (n=32/257, 12.5%). 
Pneumonia (with different codes merging on a single
clinical diagnosis) was the leading respiratory disease,
accounting for 10.5% (n=27/257) of cases. Hepatocellu-
lar carcinoma (n=19/257, 7.4%) was the most frequently
described cancer. Liver cirrhosis (n=31/257 12.1%) was
the most frequently recorded disease in the category of
digestive systems. All details of discharging diagnosis are
reported in Table 4.
DISCUSSION
In our study, the majority of patients who were admitted
had a viral load below 50 copies/ml and 68.3% of admis-
sions had a CD4 count above 200 cells/µl. This is related
to the number of patients on cART at admission (86.4%),
with more than 50% of patients on cART for more than
six months. Moreover, it suggests that the majority of ad-
missions would not be AIDS-related, but due to other co-
morbidities. Chronic HCV was the leading cause of
admission secondary to infection. This is consistent with
the mode of HIV transmission in our cohort, as 64.4%
were intravenous drug users14. The complications of HCV
(including cirrhosis and hepatocellular carcinoma) were
the most common cause of admissions (31%) and mortal-
ity (11.9%) in our cohort. The HCV data is in line with a
well-established epidemiological scenario15. The preva-
lence of HCV coinfected patients in the IT cohort is very
close to the 45% reported by the Italian Cohort of Patients
Naïve from Antiretrovirals (ICONA) in 200216. Of impor-
tance, opportunistic infections are no longer the most com-
mon cause of admission secondary to infections and this
crucial point is a clear sign of a changed epidemiology2.
Pneumonia is associated with impaired immune status
in HIV patients and recurrent pneumonias are considered
an AIDS-defining event13. However, the aging HIV pop-
ulation is experiencing increased prevalence of chronic
obstructive lung disease, with infection often being con-
sidered a trigger for exacerbations that might not simply
be related to the immune system, but also to older patient
demographic. Acute pyelonephritis are often related to
sexual activity17,18; especially among men having sex
with men. This feature is deeply related to a changing
pattern of HIV transmission in Italy19. Cardiovascular
diseases are due to a well known-feature characterized
by high prevalence of comorbidities9 and of major car-
diovascular risk factors20,21, so it is crucial to keep maxi-
mum attention to reduce the modifiable elements. The
most frequently observed neoplasms (HCC, larynx and
lung cancer) were not AIDS-defining cancers. This result
is well aligned with the epidemiological picture drawn
by Yaniket et al22, where the development of cancer is re-
lated with the time on cART. This data reflects the in-
creased cancer risk with aging.
The rate of patient admissions per 100 years observed
in our study (6) is lower than that observed in a similar
study in Canada (21) in 200323, but this may be related
to the improvements due to cART and HIV disease pro-
gression control. Duration of admission was longer than
that reported by the European Community24 for the Ital-
ian general population (8 days). However, with the com-
plications of HCV coinfection rates in IT and the
recognised impact on mortality25,26, it is likely that the
focus of care during these admissions is on severely un-
well patients and end-of-life care, that would require a
longer hospitalisation admission (average hospital stay
16 days). However, this could be improved with better
community palliative care facilities, available in other
European countries27.
Future studies should consider identifying the number
of new and follow-up diagnoses and cases for each pa-
tient admission, which may help to detect conditions that
require further support or management in the community.
Finally, these data do not reflect the whole national pic-
ture, only a local population, and therefore information
regarding ethnicity groups and female patients is limited.
Overall, the patterns of these cohorts can help to iden-
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Table 2. Cohort demographics                           
                                                                              IT n (%)
Total number of admissions                                  257
Total number of patients*                                     205
Gender (% based on total number of patients)      
– Female                                                                58 (28.3)
– Male                                                                   147 (71.7)
Average age at spell*                                            
– Median                                                               49
– IQR                                                                     45-53
Length of staying (days)                                       
– Mean average                                                     16 (±14)
No of admissions which patients 
were on ARVs                                                     222/257 (86.4)
Cd4 (cells/ml)                                                        
– Median                                                               302
– IQR                                                                     157-434
VL positive  (copies/ml log10)                               
– Median                                                               4.36
– IQR                                                                     4.04-5.10
Route of infection*
(% based on total number of patients)                
– Heterosexual sex                                                47 (22.9)
– Men who have Sex with Men                            25 (12.2)
– Drug abuse                                                         132 (64.4)
– Other/Unknown                                                 1 (0.5)
Death (mortality rate)                                            21 (10.2)
(% based on total number of patients)                
*Each patients can have more than one hospital admission
Table 3. Outcomes.
                                                                         IT n=257
Usually                                                             177 (68.9)
Died                                                                 21 (8.2)*
Hospice                                                           0 (0.0)
Temporary                                                        23 (8.9)
Other/Unknown                                               36 (14.0)
*Each patient may have more than one hospital admission before
decease                                                             
tify trends and patterns of HIV admissions in an aging
population. The impact of hepatitis coinfection and ma-
lignancy needs major attention. Importantly, strategic
planning of healthcare services needs to take into account
the impact of NICMs in the future of HIV care. This is
especially true today, that new drugs for HCV treatment
are available, with the potential to improve the quality of
life for our patients. This strategy could help saving on
direct and indirect costs for the National Health Service.
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